Capital Investment Counsel, Inc Abbott Laboratories Transaction History
Capital Investment Counsel, Inc
- $661 Million
- Q4 2024
A detailed history of Capital Investment Counsel, Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Capital Investment Counsel, Inc holds 1,981 shares of ABT stock, worth $258,738. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,981
Previous 2,106
5.94%
Holding current value
$258,738
Previous $240,000
6.67%
% of portfolio
0.03%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding ABT
# of Institutions
3,344Shares Held
1.36BCall Options Held
10.7MPut Options Held
8.87M-
Vanguard Group Inc Valley Forge, PA169MShares$22 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.1 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$10.1 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$8.88 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$7.07 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $229B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...